ImmuPharma plc (LON:IMM – Get Free Report)’s share price dropped 9% during trading on Wednesday . The stock traded as low as GBX 4.50 ($0.06) and last traded at GBX 4.55 ($0.06). Approximately 3,418,002 shares were traded during trading, a decline of 85% from the average daily volume of 22,143,848 shares. The stock had previously closed at GBX 5 ($0.06).
ImmuPharma Stock Performance
The company has a 50 day moving average price of GBX 2.39 and a 200 day moving average price of GBX 1.93. The company has a market capitalization of £21.57 million, a PE ratio of -518.00 and a beta of 1.53.
About ImmuPharma
ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.
See Also
- Five stocks we like better than ImmuPharma
- What is the MACD Indicator and How to Use it in Your Trading
- Uber’s Business, Cash Flow, and AI are Why it Will Set a New High
- Best Aerospace Stocks Investing
- Weak Guidance from Bristol-Myers Could Be Creating an Opportunity
- Special Purpose Acquisition Company (SPAC) What You Need to Know
- These are the 3 Stocks Most Likely to Split in 2025
Receive News & Ratings for ImmuPharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ImmuPharma and related companies with MarketBeat.com's FREE daily email newsletter.
